Observational analysis reveals GP-63 inhibition of retinoic acid synthesis in Leishmania donovani, suggesting targeted therapeutic avenues.
This study explores the potential mechanism by which Leishmania donovani downregulates retinoic acid (RA) synthesis to promote survival within host macrophages. Parasites were treated with varying concentrations of RA, and secreted proteins were identified via LC–MS analysis. Among these, GP‐63, a metalloprotease known to aid parasite survival by degrading host proteins was investigated for its interaction with retinaldehyde dehydrogenase 2 (RALDH2), a key enzyme in RA biosynthesis. Molecular docking revealed a strong and stable interaction between GP‐63 and RALDH2, with a highly favorable binding energy of –950.3 kJ/mol. Molecular dynamics simulations over 200 ns indicated structural stability, evidenced by an average RMSD of 1.78 Å and a consistent radius of gyration (42 Å). MM/GBSA calculations yielded a total binding energy (ΔG bind ) of –80.59 kJ/mol, while interaction entropy analysis showed an entropic contribution (–TΔS) of 88.8 kcal/mol, resulting in a net binding energy of –1.72 kcal/mol. These results suggest that GP63 directly targets RALDH2, potentially inhibiting RA synthesis and thereby enhancing parasite persistence within macrophages. This work provides molecular‐level insights into the GP63–RALDH2 interaction, offering a foundation for the development of targeted therapeutics against visceral leishmaniasis.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: